Innovation, resilience – and sympathy

Bill Gates delivers Dimbleby Lecture on polio

20130131_Dimbleby
Bill Gates standing beside an iron lung, “an example of what polio-related innovation looked like” BBC/Guy Levy, The Richard Dimbleby Lecture 2013.

January 31, 2013 – When he was invited to give this year’s prestigious Richard Dimbleby Lecture, Bill Gates could have chosen to speak about a lot of things – from the creation of the personal computer, to life as one of the world’s wealthiest people, to his role as a leading philanthropist. But instead he decided to focus on polio, using the Lecture as a chance to explain why he, along with the foundation he co-founded and the partnership it supports, is so focused on ending this disease:

For Gates, “The fight to eradicate polio stands for what we can do and who we can be. The best of who we are—our capacity for innovation, our resilience, our boundless sympathy for each other—has gotten us to this threshold.”

Gates sees the innovation that polio eradication has catalysed as a model for future efforts to deliver better health to more people. “We are on the verge of doing something we’ve never been able to do before—reaching the vast majority of children in the remotest places in the world. We are building systems, developing technology, and training workers that make it possible to help people who never got any help. When polio is gone, we can use the same systems, technology, and people to deliver other lifesaving solutions, especially routine vaccinations for diseases like rotavirus and measles.”


Related News

   19/10/2021
For a few incredible eradicators, a life’s purpose doesn’t stop at retirement
   19/10/2021
Update on polio eradication efforts in Pakistan for September 2021
   18/10/2021
WHO and UNICEF welcome the decision by the Taliban leadership supporting the resumption of house-to-house polio vaccination across Afghanistan.
   13/10/2021
Virus isolated from Rivne province in north-west of country
   10/10/2021
The recommendation further advances nOPV2 as a critical new tool in the fight against circulating vaccine-derived poliovirus type 2 (cVDPV2)
   29/09/2021
More often than not, the road to a meaningful triumph is a bumpy one.